4 months Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High – Here’s What Happened MarketBeat

Crinetics Pharmaceuticals (NASDAQ:CRNX) Sets New 1-Year High – Time to Buy?

Nasdaq 100 · Pharmaceuticals